PMID- 29202128 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 2575-615X (Electronic) IS - 2575-615X (Linking) VI - 1 IP - 3 DP - 2017 TI - "Toll-free" pathways for production of type I interferons. PG - 143-163 LID - 10.3934/Allergy.2017.3.143 [doi] AB - Pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) are recognized by different cellular pathogen recognition receptors (PRRs), which are expressed on cell membrane or in the cytoplasm of cells of the innate immune system. Nucleic acids derived from pathogens or from certain cellular conditions represent a large category of PAMPs/DAMPs that trigger production of type I interferons (IFN-I) in addition to pro-inflammatory cytokines, by specifically binding to intracellular Toll-like receptors or cytosolic receptors. These cytosolic receptors, which are not related to TLRs and we call them "Toll-free" receptors, include the RNA-sensing RIG-I like receptors (RLRs), the DNA-sensing HIN200 family, and cGAS, amongst others. Viruses have evolved myriad strategies to evoke both host cellular and viral factors to evade IFN-I-mediated innate immune responses, to facilitate their infection, replication, and establishment of latency. This review outlines these "Toll-free" innate immune pathways and recent updates on their regulation, with focus on cellular and viral factors with enzyme activities. FAU - Wang, Ling AU - Wang L AD - Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA. AD - Center of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA. FAU - Ning, Shunbin AU - Ning S AD - Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA. AD - Center of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA. LA - eng GR - R15 DE027314/DE/NIDCR NIH HHS/United States PT - Journal Article DEP - 20171106 PL - United States TA - AIMS Allergy Immunol JT - AIMS allergy and immunology JID - 101716531 PMC - PMC5710802 MID - NIHMS918441 OTO - NOTNLM OT - IFN-I OT - PRR OT - cGAS OT - innate immunity COIS- Conflict of Interest The authors declare that they have no competing interests in this paper. EDAT- 2017/12/05 06:00 MHDA- 2017/12/05 06:01 PMCR- 2017/12/01 CRDT- 2017/12/05 06:00 PHST- 2017/12/05 06:00 [entrez] PHST- 2017/12/05 06:00 [pubmed] PHST- 2017/12/05 06:01 [medline] PHST- 2017/12/01 00:00 [pmc-release] AID - 10.3934/Allergy.2017.3.143 [doi] PST - ppublish SO - AIMS Allergy Immunol. 2017;1(3):143-163. doi: 10.3934/Allergy.2017.3.143. Epub 2017 Nov 6.